Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study.
El Bairi K, Najem S, Chowdhury AR, Omar A, Abdihamid O, Teuwen LA, Benhima N, Madariaga A, Elkefi S, Diaz FC, Hussain S, Jenei K, Hammad N, Mutebi M, Rubagumya F, Trapani D, El Kadmiri N, Laouali N, Fourtassi M. El Bairi K, et al. Among authors: madariaga a. JCO Glob Oncol. 2024 May;10:e2400167. doi: 10.1200/GO.24.00167. JCO Glob Oncol. 2024. PMID: 38822759 Free PMC article.
Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients.
Vaz Salgado MA, Soto M, Reguero ME, Muñoz G, Cabañero A, Gallego I, Resano S, Longo F, Madariaga A, Gomez A, Carrato A. Vaz Salgado MA, et al. Among authors: madariaga a. Clin Transl Oncol. 2017 Mar;19(3):357-363. doi: 10.1007/s12094-016-1536-7. Epub 2016 Sep 7. Clin Transl Oncol. 2017. PMID: 27604423
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients.
Mezquita L, Benito A, Ruano-Raviña A, Zamora J, Olmedo ME, Reguera P, Madariaga A, Villamayor M, Cortez SP, Gorospe L, Santón A, Mayoralas S, Hernanz R, Cabañero A, Auclin E, Carrato A, Garrido P. Mezquita L, et al. Among authors: madariaga a. Clin Lung Cancer. 2019 Jul;20(4):305-312.e3. doi: 10.1016/j.cllc.2019.04.009. Epub 2019 May 3. Clin Lung Cancer. 2019. PMID: 31151782
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression.
Lheureux S, Oaknin A, Garg S, Bruce JP, Madariaga A, Dhani NC, Bowering V, White J, Accardi S, Tan Q, Braunstein M, Karakasis K, Cirlan I, Pedersen S, Li T, Fariñas-Madrid L, Lee YC, Liu ZA, Pugh TJ, Oza AM. Lheureux S, et al. Among authors: madariaga a. Clin Cancer Res. 2020 Aug 15;26(16):4206-4215. doi: 10.1158/1078-0432.CCR-19-4121. Epub 2020 May 22. Clin Cancer Res. 2020. PMID: 32444417 Clinical Trial.
New approaches for targeting platinum-resistant ovarian cancer.
McMullen M, Madariaga A, Lheureux S. McMullen M, et al. Among authors: madariaga a. Semin Cancer Biol. 2021 Dec;77:167-181. doi: 10.1016/j.semcancer.2020.08.013. Epub 2020 Aug 29. Semin Cancer Biol. 2021. PMID: 32871277 Review.
69 results